nodes	percent_of_prediction	percent_of_DWPC	metapath
Danazol—Prednisone—hematologic cancer	0.246	1	CrCtD
Danazol—CCL2—hematologic cancer	0.133	0.531	CbGaD
Danazol—AR—hematologic cancer	0.0665	0.265	CbGaD
Danazol—ESR1—hematologic cancer	0.0512	0.204	CbGaD
Danazol—PGR—Betamethasone—hematologic cancer	0.0277	0.193	CbGbCtD
Danazol—PGR—Dexamethasone—hematologic cancer	0.0161	0.112	CbGbCtD
Danazol—CYP19A1—Betamethasone—hematologic cancer	0.0156	0.109	CbGbCtD
Danazol—CYP19A1—Dexamethasone—hematologic cancer	0.00906	0.0632	CbGbCtD
Danazol—Testolactone—Dexamethasone—hematologic cancer	0.00879	0.0491	CrCrCtD
Danazol—Testolactone—Betamethasone—hematologic cancer	0.00879	0.0491	CrCrCtD
Danazol—Testolactone—Triamcinolone—hematologic cancer	0.00859	0.048	CrCrCtD
Danazol—Cortisone acetate—Prednisone—hematologic cancer	0.0084	0.0469	CrCrCtD
Danazol—Cortisone acetate—Prednisolone—hematologic cancer	0.0082	0.0458	CrCrCtD
Danazol—Testolactone—Prednisone—hematologic cancer	0.00815	0.0455	CrCrCtD
Danazol—Fluoxymesterone—Dexamethasone—hematologic cancer	0.00808	0.0451	CrCrCtD
Danazol—Fluoxymesterone—Betamethasone—hematologic cancer	0.00808	0.0451	CrCrCtD
Danazol—Testolactone—Prednisolone—hematologic cancer	0.00796	0.0444	CrCrCtD
Danazol—Fluoxymesterone—Triamcinolone—hematologic cancer	0.0079	0.0441	CrCrCtD
Danazol—Prednisone—Betamethasone—hematologic cancer	0.00787	0.044	CrCrCtD
Danazol—Prednisone—Dexamethasone—hematologic cancer	0.00787	0.044	CrCrCtD
Danazol—Prednisone—Triamcinolone—hematologic cancer	0.00769	0.0429	CrCrCtD
Danazol—Fluoxymesterone—Prednisolone—hematologic cancer	0.00732	0.0408	CrCrCtD
Danazol—Progesterone—Prednisolone—hematologic cancer	0.00713	0.0398	CrCrCtD
Danazol—Prednisone—Prednisolone—hematologic cancer	0.00713	0.0398	CrCrCtD
Danazol—Methyltestosterone—Prednisone—hematologic cancer	0.00712	0.0397	CrCrCtD
Danazol—Methyltestosterone—Prednisolone—hematologic cancer	0.00695	0.0388	CrCrCtD
Danazol—Hydrocortisone—Betamethasone—hematologic cancer	0.00642	0.0358	CrCrCtD
Danazol—Hydrocortisone—Dexamethasone—hematologic cancer	0.00642	0.0358	CrCrCtD
Danazol—Hydrocortisone—Triamcinolone—hematologic cancer	0.00627	0.035	CrCrCtD
Danazol—CYP3A4—Bexarotene—hematologic cancer	0.00621	0.0433	CbGbCtD
Danazol—Testosterone—Prednisolone—hematologic cancer	0.00619	0.0345	CrCrCtD
Danazol—Hydrocortisone—Prednisone—hematologic cancer	0.00595	0.0332	CrCrCtD
Danazol—Hydrocortisone—Prednisolone—hematologic cancer	0.00581	0.0324	CrCrCtD
Danazol—CYP3A4—Lomustine—hematologic cancer	0.00578	0.0403	CbGbCtD
Danazol—CYP3A4—Busulfan—hematologic cancer	0.00578	0.0403	CbGbCtD
Danazol—CYP3A4—Thiotepa—hematologic cancer	0.00515	0.0359	CbGbCtD
Danazol—PGR—ovarian follicle—hematologic cancer	0.00496	0.166	CbGeAlD
Danazol—CYP19A1—ovarian follicle—hematologic cancer	0.00446	0.149	CbGeAlD
Danazol—CYP3A4—Methoxsalen—hematologic cancer	0.004	0.0279	CbGbCtD
Danazol—ESR1—ovarian follicle—hematologic cancer	0.00388	0.13	CbGeAlD
Danazol—CYP3A4—Bortezomib—hematologic cancer	0.00381	0.0266	CbGbCtD
Danazol—CYP3A4—Daunorubicin—hematologic cancer	0.00364	0.0254	CbGbCtD
Danazol—CYP3A4—Cytarabine—hematologic cancer	0.00321	0.0224	CbGbCtD
Danazol—CYP3A4—Teniposide—hematologic cancer	0.00316	0.0221	CbGbCtD
Danazol—CYP3A4—Ifosfamide—hematologic cancer	0.00292	0.0204	CbGbCtD
Danazol—CYP3A4—Imatinib—hematologic cancer	0.00279	0.0195	CbGbCtD
Danazol—CYP3A4—Ruxolitinib—hematologic cancer	0.00263	0.0183	CbGbCtD
Danazol—CYP3A4—Nilotinib—hematologic cancer	0.00254	0.0177	CbGbCtD
Danazol—CYP3A4—Vinorelbine—hematologic cancer	0.00251	0.0175	CbGbCtD
Danazol—CYP3A4—Triamcinolone—hematologic cancer	0.0023	0.016	CbGbCtD
Danazol—CYP3A4—Dasatinib—hematologic cancer	0.00224	0.0156	CbGbCtD
Danazol—CYP3A4—Mitoxantrone—hematologic cancer	0.00221	0.0154	CbGbCtD
Danazol—CYP3A4—Betamethasone—hematologic cancer	0.00197	0.0138	CbGbCtD
Danazol—CYP3A4—Prednisolone—hematologic cancer	0.00195	0.0136	CbGbCtD
Danazol—CYP3A4—Prednisone—hematologic cancer	0.00184	0.0128	CbGbCtD
Danazol—CYP3A4—Irinotecan—hematologic cancer	0.00174	0.0122	CbGbCtD
Danazol—CYP3A4—Vinblastine—hematologic cancer	0.00155	0.0108	CbGbCtD
Danazol—CYP3A4—Vincristine—hematologic cancer	0.00152	0.0106	CbGbCtD
Danazol—CYP3A4—Etoposide—hematologic cancer	0.0014	0.00974	CbGbCtD
Danazol—CYP3A4—Dexamethasone—hematologic cancer	0.00115	0.008	CbGbCtD
Danazol—CCL2—hematopoietic system—hematologic cancer	0.00114	0.0381	CbGeAlD
Danazol—GNRHR—gonad—hematologic cancer	0.00111	0.0371	CbGeAlD
Danazol—CYP3A4—Doxorubicin—hematologic cancer	0.000952	0.00664	CbGbCtD
Danazol—GNRHR—testis—hematologic cancer	0.0008	0.0268	CbGeAlD
Danazol—CCL2—blood—hematologic cancer	0.000755	0.0253	CbGeAlD
Danazol—CCL2—bone marrow—hematologic cancer	0.00073	0.0245	CbGeAlD
Danazol—SHBG—hematopoietic system—hematologic cancer	0.000665	0.0223	CbGeAlD
Danazol—CCL2—lung—hematologic cancer	0.000662	0.0222	CbGeAlD
Danazol—CCL2—testis—hematologic cancer	0.000624	0.0209	CbGeAlD
Danazol—PGR—hematopoietic system—hematologic cancer	0.000599	0.02	CbGeAlD
Danazol—CYP19A1—hematopoietic system—hematologic cancer	0.000539	0.018	CbGeAlD
Danazol—SHBG—gonad—hematologic cancer	0.000505	0.0169	CbGeAlD
Danazol—AR—hematopoietic system—hematologic cancer	0.000477	0.016	CbGeAlD
Danazol—ESR1—hematopoietic system—hematologic cancer	0.000468	0.0157	CbGeAlD
Danazol—CCL2—lymph node—hematologic cancer	0.000452	0.0152	CbGeAlD
Danazol—SHBG—blood—hematologic cancer	0.00044	0.0147	CbGeAlD
Danazol—SHBG—bone marrow—hematologic cancer	0.000426	0.0143	CbGeAlD
Danazol—CYP19A1—gonad—hematologic cancer	0.00041	0.0137	CbGeAlD
Danazol—PGR—blood—hematologic cancer	0.000397	0.0133	CbGeAlD
Danazol—SHBG—testis—hematologic cancer	0.000364	0.0122	CbGeAlD
Danazol—AR—gonad—hematologic cancer	0.000363	0.0121	CbGeAlD
Danazol—CYP19A1—blood—hematologic cancer	0.000357	0.012	CbGeAlD
Danazol—ESR1—gonad—hematologic cancer	0.000356	0.0119	CbGeAlD
Danazol—PGR—lung—hematologic cancer	0.000348	0.0116	CbGeAlD
Danazol—PGR—testis—hematologic cancer	0.000328	0.011	CbGeAlD
Danazol—AR—blood—hematologic cancer	0.000316	0.0106	CbGeAlD
Danazol—ESR1—blood—hematologic cancer	0.00031	0.0104	CbGeAlD
Danazol—CYP19A1—testis—hematologic cancer	0.000295	0.00989	CbGeAlD
Danazol—AR—lung—hematologic cancer	0.000277	0.00928	CbGeAlD
Danazol—ESR1—lung—hematologic cancer	0.000272	0.00911	CbGeAlD
Danazol—AR—testis—hematologic cancer	0.000261	0.00875	CbGeAlD
Danazol—CYP3A4—hematopoietic system—hematologic cancer	0.000261	0.00875	CbGeAlD
Danazol—ESR1—testis—hematologic cancer	0.000257	0.00859	CbGeAlD
Danazol—PGR—lymph node—hematologic cancer	0.000238	0.00796	CbGeAlD
Danazol—CYP19A1—lymph node—hematologic cancer	0.000214	0.00717	CbGeAlD
Danazol—Stanozolol—AR—hematologic cancer	0.000197	0.101	CrCbGaD
Danazol—AR—lymph node—hematologic cancer	0.000189	0.00634	CbGeAlD
Danazol—ESR1—lymph node—hematologic cancer	0.000186	0.00623	CbGeAlD
Danazol—Oxandrolone—AR—hematologic cancer	0.000177	0.0907	CrCbGaD
Danazol—CYP3A4—blood—hematologic cancer	0.000173	0.0058	CbGeAlD
Danazol—Quinestrol—ESR1—hematologic cancer	0.000126	0.0643	CrCbGaD
Danazol—Testosterone Propionate—UGT1A1—hematologic cancer	0.000101	0.0515	CrCbGaD
Danazol—Mestranol—ESR1—hematologic cancer	9.53e-05	0.0487	CrCbGaD
Danazol—Trilostane—ESR1—hematologic cancer	9.53e-05	0.0487	CrCbGaD
Danazol—Desogestrel—ESR1—hematologic cancer	9.42e-05	0.0481	CrCbGaD
Danazol—Etonogestrel—ESR1—hematologic cancer	7.62e-05	0.0389	CrCbGaD
Danazol—Testosterone Propionate—AR—hematologic cancer	7.2e-05	0.0368	CrCbGaD
Danazol—Levonorgestrel—AR—hematologic cancer	7e-05	0.0358	CrCbGaD
Danazol—Cortisone acetate—NR3C1—hematologic cancer	6.91e-05	0.0353	CrCbGaD
Danazol—Fluoxymesterone—AR—hematologic cancer	6.67e-05	0.0341	CrCbGaD
Danazol—Levonorgestrel—ESR1—hematologic cancer	5.39e-05	0.0275	CrCbGaD
Danazol—Methyltestosterone—AR—hematologic cancer	5.39e-05	0.0275	CrCbGaD
Danazol—CCL2—Methylprednisolone—Betamethasone—hematologic cancer	5.2e-05	0.0275	CbGdCrCtD
Danazol—CCL2—Methylprednisolone—Dexamethasone—hematologic cancer	5.2e-05	0.0275	CbGdCrCtD
Danazol—Fluoxymesterone—ESR1—hematologic cancer	5.14e-05	0.0263	CrCbGaD
Danazol—CCL2—Methylprednisolone—Triamcinolone—hematologic cancer	5.08e-05	0.0269	CbGdCrCtD
Danazol—CCL2—Methylprednisolone—Prednisone—hematologic cancer	4.82e-05	0.0255	CbGdCrCtD
Danazol—CCL2—Methylprednisolone—Prednisolone—hematologic cancer	4.7e-05	0.0249	CbGdCrCtD
Danazol—CCL2—Beclomethasone—Betamethasone—hematologic cancer	4.66e-05	0.0247	CbGdCrCtD
Danazol—CCL2—Beclomethasone—Dexamethasone—hematologic cancer	4.66e-05	0.0247	CbGdCrCtD
Danazol—CCL2—Beclomethasone—Triamcinolone—hematologic cancer	4.55e-05	0.0241	CbGdCrCtD
Danazol—Ethinyl Estradiol—ESR1—hematologic cancer	4.54e-05	0.0232	CrCbGaD
Danazol—Fluoxymesterone—NR3C1—hematologic cancer	4.52e-05	0.0231	CrCbGaD
Danazol—CCL2—Fluocinonide—Dexamethasone—hematologic cancer	4.3e-05	0.0228	CbGdCrCtD
Danazol—CCL2—Fluocinonide—Betamethasone—hematologic cancer	4.3e-05	0.0228	CbGdCrCtD
Danazol—CCL2—Beclomethasone—Prednisolone—hematologic cancer	4.22e-05	0.0223	CbGdCrCtD
Danazol—CCL2—Fluocinonide—Triamcinolone—hematologic cancer	4.2e-05	0.0223	CbGdCrCtD
Danazol—CCL2—Amcinonide—Betamethasone—hematologic cancer	4.12e-05	0.0218	CbGdCrCtD
Danazol—CCL2—Amcinonide—Dexamethasone—hematologic cancer	4.12e-05	0.0218	CbGdCrCtD
Danazol—CCL2—Amcinonide—Triamcinolone—hematologic cancer	4.03e-05	0.0213	CbGdCrCtD
Danazol—Prednisone—NR3C1—hematologic cancer	3.9e-05	0.0199	CrCbGaD
Danazol—CCL2—Amcinonide—Prednisone—hematologic cancer	3.82e-05	0.0203	CbGdCrCtD
Danazol—CCL2—Amcinonide—Prednisolone—hematologic cancer	3.73e-05	0.0198	CbGdCrCtD
Danazol—Progesterone—SLC22A1—hematologic cancer	3.72e-05	0.019	CrCbGaD
Danazol—Testosterone—SLC22A1—hematologic cancer	3.52e-05	0.018	CrCbGaD
Danazol—Progesterone—AR—hematologic cancer	3.31e-05	0.0169	CrCbGaD
Danazol—CCL2—Fluorometholone—Betamethasone—hematologic cancer	3.22e-05	0.0171	CbGdCrCtD
Danazol—CCL2—Fluorometholone—Dexamethasone—hematologic cancer	3.22e-05	0.0171	CbGdCrCtD
Danazol—CCL2—Flurandrenolide—Betamethasone—hematologic cancer	3.2e-05	0.017	CbGdCrCtD
Danazol—CCL2—Flurandrenolide—Dexamethasone—hematologic cancer	3.2e-05	0.017	CbGdCrCtD
Danazol—Hydrocortisone—ABCG2—hematologic cancer	3.19e-05	0.0163	CrCbGaD
Danazol—CCL2—Fluorometholone—Triamcinolone—hematologic cancer	3.15e-05	0.0167	CbGdCrCtD
Danazol—Testosterone—AR—hematologic cancer	3.13e-05	0.016	CrCbGaD
Danazol—CCL2—Fluorometholone—Prednisone—hematologic cancer	2.99e-05	0.0158	CbGdCrCtD
Danazol—CCL2—Fluorometholone—Prednisolone—hematologic cancer	2.92e-05	0.0154	CbGdCrCtD
Danazol—CCL2—Flurandrenolide—Prednisolone—hematologic cancer	2.9e-05	0.0154	CbGdCrCtD
Danazol—Hydrocortisone—NR3C1—hematologic cancer	2.75e-05	0.0141	CrCbGaD
Danazol—CCL2—Clobetasol propionate—Dexamethasone—hematologic cancer	2.72e-05	0.0144	CbGdCrCtD
Danazol—CCL2—Clobetasol propionate—Betamethasone—hematologic cancer	2.72e-05	0.0144	CbGdCrCtD
Danazol—CCL2—Flunisolide—Betamethasone—hematologic cancer	2.69e-05	0.0142	CbGdCrCtD
Danazol—CCL2—Flunisolide—Dexamethasone—hematologic cancer	2.69e-05	0.0142	CbGdCrCtD
Danazol—CCL2—Clobetasol propionate—Triamcinolone—hematologic cancer	2.66e-05	0.0141	CbGdCrCtD
Danazol—CCL2—Triamcinolone—Betamethasone—hematologic cancer	2.66e-05	0.0141	CbGdCrCtD
Danazol—CCL2—Triamcinolone—Dexamethasone—hematologic cancer	2.66e-05	0.0141	CbGdCrCtD
Danazol—CCL2—Flunisolide—Triamcinolone—hematologic cancer	2.63e-05	0.0139	CbGdCrCtD
Danazol—CCL2—Fluticasone Propionate—Betamethasone—hematologic cancer	2.6e-05	0.0137	CbGdCrCtD
Danazol—CCL2—Fluticasone Propionate—Dexamethasone—hematologic cancer	2.6e-05	0.0137	CbGdCrCtD
Danazol—Progesterone—ESR1—hematologic cancer	2.55e-05	0.013	CrCbGaD
Danazol—CCL2—Fluticasone Propionate—Triamcinolone—hematologic cancer	2.54e-05	0.0134	CbGdCrCtD
Danazol—CCL2—Desoximetasone—Betamethasone—hematologic cancer	2.53e-05	0.0134	CbGdCrCtD
Danazol—CCL2—Desoximetasone—Dexamethasone—hematologic cancer	2.53e-05	0.0134	CbGdCrCtD
Danazol—CCL2—Clobetasol propionate—Prednisone—hematologic cancer	2.53e-05	0.0134	CbGdCrCtD
Danazol—CCL2—Flunisolide—Prednisone—hematologic cancer	2.49e-05	0.0132	CbGdCrCtD
Danazol—CCL2—Desoximetasone—Triamcinolone—hematologic cancer	2.47e-05	0.0131	CbGdCrCtD
Danazol—CCL2—Triamcinolone—Prednisone—hematologic cancer	2.47e-05	0.0131	CbGdCrCtD
Danazol—CCL2—Clobetasol propionate—Prednisolone—hematologic cancer	2.47e-05	0.0131	CbGdCrCtD
Danazol—Testosterone—ABCG2—hematologic cancer	2.46e-05	0.0126	CrCbGaD
Danazol—CCL2—Diflorasone—Dexamethasone—hematologic cancer	2.45e-05	0.013	CbGdCrCtD
Danazol—CCL2—Diflorasone—Betamethasone—hematologic cancer	2.45e-05	0.013	CbGdCrCtD
Danazol—CCL2—Flunisolide—Prednisolone—hematologic cancer	2.43e-05	0.0129	CbGdCrCtD
Danazol—CCL2—Triamcinolone—Prednisolone—hematologic cancer	2.41e-05	0.0128	CbGdCrCtD
Danazol—CCL2—Diflorasone—Triamcinolone—hematologic cancer	2.4e-05	0.0127	CbGdCrCtD
Danazol—CCL2—Desoximetasone—Prednisone—hematologic cancer	2.34e-05	0.0124	CbGdCrCtD
Danazol—CCL2—Desoximetasone—Prednisolone—hematologic cancer	2.29e-05	0.0121	CbGdCrCtD
Danazol—CCL2—Diflorasone—Prednisone—hematologic cancer	2.27e-05	0.012	CbGdCrCtD
Danazol—Progesterone—NR3C1—hematologic cancer	2.24e-05	0.0115	CrCbGaD
Danazol—CCL2—Diflorasone—Prednisolone—hematologic cancer	2.22e-05	0.0118	CbGdCrCtD
Danazol—CCL2—Budesonide—Betamethasone—hematologic cancer	2.15e-05	0.0114	CbGdCrCtD
Danazol—CCL2—Budesonide—Dexamethasone—hematologic cancer	2.15e-05	0.0114	CbGdCrCtD
Danazol—CCL2—Budesonide—Triamcinolone—hematologic cancer	2.1e-05	0.0111	CbGdCrCtD
Danazol—CCL2—Budesonide—Prednisone—hematologic cancer	1.99e-05	0.0106	CbGdCrCtD
Danazol—Prednisone—ALB—hematologic cancer	1.97e-05	0.0101	CrCbGaD
Danazol—CCL2—Budesonide—Prednisolone—hematologic cancer	1.95e-05	0.0103	CbGdCrCtD
Danazol—Norethindrone—ALB—hematologic cancer	1.95e-05	0.00994	CrCbGaD
Danazol—Ethinyl Estradiol—ABCB1—hematologic cancer	1.93e-05	0.00986	CrCbGaD
Danazol—Prednisone—ABCB1—hematologic cancer	1.88e-05	0.00962	CrCbGaD
Danazol—Norethindrone—ABCB1—hematologic cancer	1.86e-05	0.00948	CrCbGaD
Danazol—Methyltestosterone—ALB—hematologic cancer	1.85e-05	0.00944	CrCbGaD
Danazol—Vision blurred—Prednisone—hematologic cancer	1.67e-05	0.000186	CcSEcCtD
Danazol—Nausea—Thiotepa—hematologic cancer	1.66e-05	0.000186	CcSEcCtD
Danazol—Musculoskeletal discomfort—Triamcinolone—hematologic cancer	1.66e-05	0.000186	CcSEcCtD
Danazol—Oedema—Dexamethasone—hematologic cancer	1.66e-05	0.000185	CcSEcCtD
Danazol—Oedema—Betamethasone—hematologic cancer	1.66e-05	0.000185	CcSEcCtD
Danazol—Vomiting—Carmustine—hematologic cancer	1.65e-05	0.000185	CcSEcCtD
Danazol—Dizziness—Vincristine—hematologic cancer	1.64e-05	0.000183	CcSEcCtD
Danazol—Rash—Carmustine—hematologic cancer	1.64e-05	0.000183	CcSEcCtD
Danazol—Dermatitis—Carmustine—hematologic cancer	1.64e-05	0.000183	CcSEcCtD
Danazol—Vomiting—Alitretinoin—hematologic cancer	1.64e-05	0.000183	CcSEcCtD
Danazol—Paraesthesia—Triamcinolone—hematologic cancer	1.64e-05	0.000183	CcSEcCtD
Danazol—Visual impairment—Methotrexate—hematologic cancer	1.63e-05	0.000183	CcSEcCtD
Danazol—Headache—Carmustine—hematologic cancer	1.63e-05	0.000182	CcSEcCtD
Danazol—Shock—Dexamethasone—hematologic cancer	1.63e-05	0.000182	CcSEcCtD
Danazol—Shock—Betamethasone—hematologic cancer	1.63e-05	0.000182	CcSEcCtD
Danazol—Rash—Alitretinoin—hematologic cancer	1.63e-05	0.000181	CcSEcCtD
Danazol—Dermatitis—Alitretinoin—hematologic cancer	1.62e-05	0.000181	CcSEcCtD
Danazol—Stevens-Johnson syndrome—Doxorubicin—hematologic cancer	1.62e-05	0.000181	CcSEcCtD
Danazol—Thrombocytopenia—Betamethasone—hematologic cancer	1.62e-05	0.000181	CcSEcCtD
Danazol—Thrombocytopenia—Dexamethasone—hematologic cancer	1.62e-05	0.000181	CcSEcCtD
Danazol—Vomiting—Ifosfamide—hematologic cancer	1.62e-05	0.000181	CcSEcCtD
Danazol—Tachycardia—Dexamethasone—hematologic cancer	1.62e-05	0.00018	CcSEcCtD
Danazol—Tachycardia—Betamethasone—hematologic cancer	1.62e-05	0.00018	CcSEcCtD
Danazol—Headache—Alitretinoin—hematologic cancer	1.61e-05	0.00018	CcSEcCtD
Danazol—Nausea—Thalidomide—hematologic cancer	1.61e-05	0.00018	CcSEcCtD
Danazol—Dyspepsia—Triamcinolone—hematologic cancer	1.61e-05	0.000179	CcSEcCtD
Danazol—Rash—Ifosfamide—hematologic cancer	1.61e-05	0.000179	CcSEcCtD
Danazol—Dermatitis—Ifosfamide—hematologic cancer	1.6e-05	0.000179	CcSEcCtD
Danazol—Erythema multiforme—Methotrexate—hematologic cancer	1.6e-05	0.000179	CcSEcCtD
Danazol—Hyperhidrosis—Dexamethasone—hematologic cancer	1.6e-05	0.000179	CcSEcCtD
Danazol—Hyperhidrosis—Betamethasone—hematologic cancer	1.6e-05	0.000179	CcSEcCtD
Danazol—Dizziness—Irinotecan—hematologic cancer	1.6e-05	0.000179	CcSEcCtD
Danazol—Urticaria—Etoposide—hematologic cancer	1.6e-05	0.000178	CcSEcCtD
Danazol—Haemoglobin—Epirubicin—hematologic cancer	1.6e-05	0.000178	CcSEcCtD
Danazol—Jaundice—Doxorubicin—hematologic cancer	1.59e-05	0.000178	CcSEcCtD
Danazol—Body temperature increased—Etoposide—hematologic cancer	1.59e-05	0.000178	CcSEcCtD
Danazol—Vertigo—Prednisone—hematologic cancer	1.59e-05	0.000177	CcSEcCtD
Danazol—Haemorrhage—Epirubicin—hematologic cancer	1.59e-05	0.000177	CcSEcCtD
Danazol—Syncope—Prednisone—hematologic cancer	1.58e-05	0.000177	CcSEcCtD
Danazol—Vomiting—Vincristine—hematologic cancer	1.58e-05	0.000176	CcSEcCtD
Danazol—Urticaria—Prednisolone—hematologic cancer	1.58e-05	0.000176	CcSEcCtD
Danazol—Asthenia—Cisplatin—hematologic cancer	1.58e-05	0.000176	CcSEcCtD
Danazol—Fatigue—Triamcinolone—hematologic cancer	1.57e-05	0.000176	CcSEcCtD
Danazol—Sweating—Doxorubicin—hematologic cancer	1.57e-05	0.000175	CcSEcCtD
Danazol—Rash—Vincristine—hematologic cancer	1.57e-05	0.000175	CcSEcCtD
Danazol—Dermatitis—Vincristine—hematologic cancer	1.56e-05	0.000175	CcSEcCtD
Danazol—Haematuria—Doxorubicin—hematologic cancer	1.56e-05	0.000174	CcSEcCtD
Danazol—Headache—Vincristine—hematologic cancer	1.56e-05	0.000174	CcSEcCtD
Danazol—Loss of consciousness—Prednisone—hematologic cancer	1.55e-05	0.000173	CcSEcCtD
Danazol—Nausea—Carmustine—hematologic cancer	1.55e-05	0.000173	CcSEcCtD
Danazol—Vomiting—Irinotecan—hematologic cancer	1.54e-05	0.000172	CcSEcCtD
Danazol—Vomiting—Mitoxantrone—hematologic cancer	1.54e-05	0.000172	CcSEcCtD
Danazol—Nausea—Alitretinoin—hematologic cancer	1.53e-05	0.000171	CcSEcCtD
Danazol—Convulsion—Prednisone—hematologic cancer	1.53e-05	0.000171	CcSEcCtD
Danazol—Visual impairment—Epirubicin—hematologic cancer	1.53e-05	0.000171	CcSEcCtD
Danazol—Hypertension—Prednisone—hematologic cancer	1.53e-05	0.00017	CcSEcCtD
Danazol—Rash—Irinotecan—hematologic cancer	1.53e-05	0.00017	CcSEcCtD
Danazol—Rash—Mitoxantrone—hematologic cancer	1.53e-05	0.00017	CcSEcCtD
Danazol—Dermatitis—Mitoxantrone—hematologic cancer	1.52e-05	0.00017	CcSEcCtD
Danazol—Dermatitis—Irinotecan—hematologic cancer	1.52e-05	0.00017	CcSEcCtD
Danazol—Chills—Methotrexate—hematologic cancer	1.52e-05	0.00017	CcSEcCtD
Danazol—Headache—Mitoxantrone—hematologic cancer	1.52e-05	0.000169	CcSEcCtD
Danazol—Headache—Irinotecan—hematologic cancer	1.52e-05	0.000169	CcSEcCtD
Danazol—Nausea—Ifosfamide—hematologic cancer	1.51e-05	0.000169	CcSEcCtD
Danazol—Musculoskeletal discomfort—Betamethasone—hematologic cancer	1.51e-05	0.000168	CcSEcCtD
Danazol—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	1.51e-05	0.000168	CcSEcCtD
Danazol—Arthralgia—Prednisone—hematologic cancer	1.5e-05	0.000168	CcSEcCtD
Danazol—Erythema multiforme—Epirubicin—hematologic cancer	1.5e-05	0.000168	CcSEcCtD
Danazol—Anxiety—Prednisone—hematologic cancer	1.5e-05	0.000167	CcSEcCtD
Danazol—Alopecia—Methotrexate—hematologic cancer	1.5e-05	0.000167	CcSEcCtD
Danazol—Vomiting—Gemcitabine—hematologic cancer	1.5e-05	0.000167	CcSEcCtD
Danazol—Paraesthesia—Betamethasone—hematologic cancer	1.49e-05	0.000166	CcSEcCtD
Danazol—Paraesthesia—Dexamethasone—hematologic cancer	1.49e-05	0.000166	CcSEcCtD
Danazol—Rash—Gemcitabine—hematologic cancer	1.49e-05	0.000166	CcSEcCtD
Danazol—Dermatitis—Gemcitabine—hematologic cancer	1.48e-05	0.000166	CcSEcCtD
Danazol—Haemoglobin—Doxorubicin—hematologic cancer	1.48e-05	0.000165	CcSEcCtD
Danazol—Headache—Gemcitabine—hematologic cancer	1.48e-05	0.000165	CcSEcCtD
Danazol—Nausea—Vincristine—hematologic cancer	1.48e-05	0.000165	CcSEcCtD
Danazol—Flushing—Epirubicin—hematologic cancer	1.47e-05	0.000164	CcSEcCtD
Danazol—Haemorrhage—Doxorubicin—hematologic cancer	1.47e-05	0.000164	CcSEcCtD
Danazol—Dyspepsia—Betamethasone—hematologic cancer	1.46e-05	0.000163	CcSEcCtD
Danazol—Dyspepsia—Dexamethasone—hematologic cancer	1.46e-05	0.000163	CcSEcCtD
Danazol—Urticaria—Triamcinolone—hematologic cancer	1.45e-05	0.000162	CcSEcCtD
Danazol—Asthenia—Etoposide—hematologic cancer	1.44e-05	0.000161	CcSEcCtD
Danazol—Body temperature increased—Triamcinolone—hematologic cancer	1.44e-05	0.000161	CcSEcCtD
Danazol—Oedema—Prednisone—hematologic cancer	1.44e-05	0.000161	CcSEcCtD
Danazol—Nausea—Mitoxantrone—hematologic cancer	1.44e-05	0.00016	CcSEcCtD
Danazol—Nausea—Irinotecan—hematologic cancer	1.44e-05	0.00016	CcSEcCtD
Danazol—Back pain—Methotrexate—hematologic cancer	1.43e-05	0.000159	CcSEcCtD
Danazol—Fatigue—Betamethasone—hematologic cancer	1.43e-05	0.000159	CcSEcCtD
Danazol—Fatigue—Dexamethasone—hematologic cancer	1.43e-05	0.000159	CcSEcCtD
Danazol—Chills—Epirubicin—hematologic cancer	1.42e-05	0.000159	CcSEcCtD
Danazol—Pruritus—Etoposide—hematologic cancer	1.42e-05	0.000159	CcSEcCtD
Danazol—Shock—Prednisone—hematologic cancer	1.42e-05	0.000158	CcSEcCtD
Danazol—Visual impairment—Doxorubicin—hematologic cancer	1.42e-05	0.000158	CcSEcCtD
Danazol—Tachycardia—Prednisone—hematologic cancer	1.41e-05	0.000157	CcSEcCtD
Danazol—Alopecia—Epirubicin—hematologic cancer	1.4e-05	0.000157	CcSEcCtD
Danazol—Nausea—Gemcitabine—hematologic cancer	1.4e-05	0.000156	CcSEcCtD
Danazol—Vomiting—Cisplatin—hematologic cancer	1.4e-05	0.000156	CcSEcCtD
Danazol—Hyperhidrosis—Prednisone—hematologic cancer	1.39e-05	0.000156	CcSEcCtD
Danazol—Vision blurred—Methotrexate—hematologic cancer	1.39e-05	0.000155	CcSEcCtD
Danazol—Erythema multiforme—Doxorubicin—hematologic cancer	1.39e-05	0.000155	CcSEcCtD
Danazol—Rash—Cisplatin—hematologic cancer	1.38e-05	0.000155	CcSEcCtD
Danazol—Dermatitis—Cisplatin—hematologic cancer	1.38e-05	0.000154	CcSEcCtD
Danazol—Flushing—Doxorubicin—hematologic cancer	1.36e-05	0.000152	CcSEcCtD
Danazol—Tension—Epirubicin—hematologic cancer	1.36e-05	0.000151	CcSEcCtD
Danazol—Nervousness—Epirubicin—hematologic cancer	1.34e-05	0.00015	CcSEcCtD
Danazol—Back pain—Epirubicin—hematologic cancer	1.34e-05	0.000149	CcSEcCtD
Danazol—Dizziness—Etoposide—hematologic cancer	1.33e-05	0.000149	CcSEcCtD
Danazol—Muscle spasms—Epirubicin—hematologic cancer	1.33e-05	0.000148	CcSEcCtD
Danazol—Hydrocortisone—ABCB1—hematologic cancer	1.33e-05	0.00678	CrCbGaD
Danazol—Vertigo—Methotrexate—hematologic cancer	1.33e-05	0.000148	CcSEcCtD
Danazol—Leukopenia—Methotrexate—hematologic cancer	1.32e-05	0.000148	CcSEcCtD
Danazol—Chills—Doxorubicin—hematologic cancer	1.32e-05	0.000147	CcSEcCtD
Danazol—CCL2—Betamethasone—Dexamethasone—hematologic cancer	1.32e-05	0.00697	CbGdCrCtD
Danazol—CCL2—Dexamethasone—Betamethasone—hematologic cancer	1.32e-05	0.00697	CbGdCrCtD
Danazol—Urticaria—Betamethasone—hematologic cancer	1.32e-05	0.000147	CcSEcCtD
Danazol—Urticaria—Dexamethasone—hematologic cancer	1.32e-05	0.000147	CcSEcCtD
Danazol—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.31e-05	0.000147	CcSEcCtD
Danazol—Dizziness—Prednisolone—hematologic cancer	1.31e-05	0.000147	CcSEcCtD
Danazol—Asthenia—Triamcinolone—hematologic cancer	1.31e-05	0.000146	CcSEcCtD
Danazol—Body temperature increased—Dexamethasone—hematologic cancer	1.31e-05	0.000146	CcSEcCtD
Danazol—Body temperature increased—Betamethasone—hematologic cancer	1.31e-05	0.000146	CcSEcCtD
Danazol—Nausea—Cisplatin—hematologic cancer	1.3e-05	0.000146	CcSEcCtD
Danazol—Vision blurred—Epirubicin—hematologic cancer	1.3e-05	0.000145	CcSEcCtD
Danazol—Alopecia—Doxorubicin—hematologic cancer	1.3e-05	0.000145	CcSEcCtD
Danazol—Paraesthesia—Prednisone—hematologic cancer	1.29e-05	0.000145	CcSEcCtD
Danazol—Pruritus—Triamcinolone—hematologic cancer	1.29e-05	0.000144	CcSEcCtD
Danazol—CCL2—Betamethasone—Triamcinolone—hematologic cancer	1.29e-05	0.00681	CbGdCrCtD
Danazol—CCL2—Dexamethasone—Triamcinolone—hematologic cancer	1.29e-05	0.00681	CbGdCrCtD
Danazol—Convulsion—Methotrexate—hematologic cancer	1.28e-05	0.000143	CcSEcCtD
Danazol—Vomiting—Etoposide—hematologic cancer	1.28e-05	0.000143	CcSEcCtD
Danazol—Dyspepsia—Prednisone—hematologic cancer	1.27e-05	0.000142	CcSEcCtD
Danazol—Rash—Etoposide—hematologic cancer	1.27e-05	0.000142	CcSEcCtD
Danazol—Dermatitis—Etoposide—hematologic cancer	1.27e-05	0.000142	CcSEcCtD
Danazol—Headache—Etoposide—hematologic cancer	1.26e-05	0.000141	CcSEcCtD
Danazol—Arthralgia—Methotrexate—hematologic cancer	1.26e-05	0.00014	CcSEcCtD
Danazol—Tension—Doxorubicin—hematologic cancer	1.25e-05	0.00014	CcSEcCtD
Danazol—Rash—Prednisolone—hematologic cancer	1.25e-05	0.00014	CcSEcCtD
Danazol—Dermatitis—Prednisolone—hematologic cancer	1.25e-05	0.00014	CcSEcCtD
Danazol—Fatigue—Prednisone—hematologic cancer	1.24e-05	0.000139	CcSEcCtD
Danazol—Headache—Prednisolone—hematologic cancer	1.24e-05	0.000139	CcSEcCtD
Danazol—Nervousness—Doxorubicin—hematologic cancer	1.24e-05	0.000139	CcSEcCtD
Danazol—Vertigo—Epirubicin—hematologic cancer	1.24e-05	0.000139	CcSEcCtD
Danazol—Syncope—Epirubicin—hematologic cancer	1.24e-05	0.000138	CcSEcCtD
Danazol—Leukopenia—Epirubicin—hematologic cancer	1.24e-05	0.000138	CcSEcCtD
Danazol—Back pain—Doxorubicin—hematologic cancer	1.24e-05	0.000138	CcSEcCtD
Danazol—Constipation—Prednisone—hematologic cancer	1.23e-05	0.000138	CcSEcCtD
Danazol—Muscle spasms—Doxorubicin—hematologic cancer	1.23e-05	0.000137	CcSEcCtD
Danazol—Palpitations—Epirubicin—hematologic cancer	1.22e-05	0.000136	CcSEcCtD
Danazol—CCL2—Betamethasone—Prednisone—hematologic cancer	1.22e-05	0.00646	CbGdCrCtD
Danazol—CCL2—Dexamethasone—Prednisone—hematologic cancer	1.22e-05	0.00646	CbGdCrCtD
Danazol—Loss of consciousness—Epirubicin—hematologic cancer	1.21e-05	0.000136	CcSEcCtD
Danazol—Dizziness—Triamcinolone—hematologic cancer	1.21e-05	0.000135	CcSEcCtD
Danazol—Vision blurred—Doxorubicin—hematologic cancer	1.21e-05	0.000135	CcSEcCtD
Danazol—Convulsion—Epirubicin—hematologic cancer	1.2e-05	0.000134	CcSEcCtD
Danazol—Nausea—Etoposide—hematologic cancer	1.2e-05	0.000133	CcSEcCtD
Danazol—Hypertension—Epirubicin—hematologic cancer	1.19e-05	0.000133	CcSEcCtD
Danazol—CCL2—Dexamethasone—Prednisolone—hematologic cancer	1.19e-05	0.00631	CbGdCrCtD
Danazol—CCL2—Betamethasone—Prednisolone—hematologic cancer	1.19e-05	0.00631	CbGdCrCtD
Danazol—Asthenia—Betamethasone—hematologic cancer	1.19e-05	0.000133	CcSEcCtD
Danazol—Asthenia—Dexamethasone—hematologic cancer	1.19e-05	0.000133	CcSEcCtD
Danazol—Thrombocytopenia—Methotrexate—hematologic cancer	1.18e-05	0.000132	CcSEcCtD
Danazol—Nausea—Prednisolone—hematologic cancer	1.18e-05	0.000132	CcSEcCtD
Danazol—Arthralgia—Epirubicin—hematologic cancer	1.18e-05	0.000131	CcSEcCtD
Danazol—Anxiety—Epirubicin—hematologic cancer	1.17e-05	0.000131	CcSEcCtD
Danazol—Pruritus—Betamethasone—hematologic cancer	1.17e-05	0.000131	CcSEcCtD
Danazol—Pruritus—Dexamethasone—hematologic cancer	1.17e-05	0.000131	CcSEcCtD
Danazol—Hyperhidrosis—Methotrexate—hematologic cancer	1.17e-05	0.00013	CcSEcCtD
Danazol—Vomiting—Triamcinolone—hematologic cancer	1.16e-05	0.00013	CcSEcCtD
Danazol—Rash—Triamcinolone—hematologic cancer	1.15e-05	0.000128	CcSEcCtD
Danazol—Dermatitis—Triamcinolone—hematologic cancer	1.15e-05	0.000128	CcSEcCtD
Danazol—Vertigo—Doxorubicin—hematologic cancer	1.15e-05	0.000128	CcSEcCtD
Danazol—Syncope—Doxorubicin—hematologic cancer	1.15e-05	0.000128	CcSEcCtD
Danazol—Urticaria—Prednisone—hematologic cancer	1.15e-05	0.000128	CcSEcCtD
Danazol—Leukopenia—Doxorubicin—hematologic cancer	1.14e-05	0.000128	CcSEcCtD
Danazol—Headache—Triamcinolone—hematologic cancer	1.14e-05	0.000128	CcSEcCtD
Danazol—Body temperature increased—Prednisone—hematologic cancer	1.14e-05	0.000127	CcSEcCtD
Danazol—Palpitations—Doxorubicin—hematologic cancer	1.13e-05	0.000126	CcSEcCtD
Danazol—Oedema—Epirubicin—hematologic cancer	1.13e-05	0.000126	CcSEcCtD
Danazol—Loss of consciousness—Doxorubicin—hematologic cancer	1.12e-05	0.000125	CcSEcCtD
Danazol—Shock—Epirubicin—hematologic cancer	1.11e-05	0.000124	CcSEcCtD
Danazol—Convulsion—Doxorubicin—hematologic cancer	1.11e-05	0.000124	CcSEcCtD
Danazol—Thrombocytopenia—Epirubicin—hematologic cancer	1.1e-05	0.000123	CcSEcCtD
Danazol—Hypertension—Doxorubicin—hematologic cancer	1.1e-05	0.000123	CcSEcCtD
Danazol—Tachycardia—Epirubicin—hematologic cancer	1.1e-05	0.000123	CcSEcCtD
Danazol—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.1e-05	0.000123	CcSEcCtD
Danazol—Dizziness—Dexamethasone—hematologic cancer	1.09e-05	0.000122	CcSEcCtD
Danazol—Dizziness—Betamethasone—hematologic cancer	1.09e-05	0.000122	CcSEcCtD
Danazol—Hyperhidrosis—Epirubicin—hematologic cancer	1.09e-05	0.000122	CcSEcCtD
Danazol—Arthralgia—Doxorubicin—hematologic cancer	1.09e-05	0.000122	CcSEcCtD
Danazol—Anxiety—Doxorubicin—hematologic cancer	1.08e-05	0.000121	CcSEcCtD
Danazol—Nausea—Triamcinolone—hematologic cancer	1.08e-05	0.000121	CcSEcCtD
Danazol—Paraesthesia—Methotrexate—hematologic cancer	1.08e-05	0.000121	CcSEcCtD
Danazol—Progesterone—ABCB1—hematologic cancer	1.08e-05	0.00553	CrCbGaD
Danazol—Testosterone—ALB—hematologic cancer	1.07e-05	0.00547	CrCbGaD
Danazol—Dyspepsia—Methotrexate—hematologic cancer	1.06e-05	0.000118	CcSEcCtD
Danazol—Vomiting—Betamethasone—hematologic cancer	1.05e-05	0.000118	CcSEcCtD
Danazol—Vomiting—Dexamethasone—hematologic cancer	1.05e-05	0.000118	CcSEcCtD
Danazol—Rash—Betamethasone—hematologic cancer	1.04e-05	0.000117	CcSEcCtD
Danazol—Rash—Dexamethasone—hematologic cancer	1.04e-05	0.000117	CcSEcCtD
Danazol—Oedema—Doxorubicin—hematologic cancer	1.04e-05	0.000117	CcSEcCtD
Danazol—Dermatitis—Betamethasone—hematologic cancer	1.04e-05	0.000116	CcSEcCtD
Danazol—Dermatitis—Dexamethasone—hematologic cancer	1.04e-05	0.000116	CcSEcCtD
Danazol—Fatigue—Methotrexate—hematologic cancer	1.04e-05	0.000116	CcSEcCtD
Danazol—Headache—Dexamethasone—hematologic cancer	1.04e-05	0.000116	CcSEcCtD
Danazol—Headache—Betamethasone—hematologic cancer	1.04e-05	0.000116	CcSEcCtD
Danazol—Asthenia—Prednisone—hematologic cancer	1.03e-05	0.000116	CcSEcCtD
Danazol—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.03e-05	0.000115	CcSEcCtD
Danazol—Shock—Doxorubicin—hematologic cancer	1.03e-05	0.000115	CcSEcCtD
Danazol—Testosterone—ABCB1—hematologic cancer	1.02e-05	0.00522	CrCbGaD
Danazol—Thrombocytopenia—Doxorubicin—hematologic cancer	1.02e-05	0.000114	CcSEcCtD
Danazol—Pruritus—Prednisone—hematologic cancer	1.02e-05	0.000114	CcSEcCtD
Danazol—Tachycardia—Doxorubicin—hematologic cancer	1.02e-05	0.000114	CcSEcCtD
Danazol—Paraesthesia—Epirubicin—hematologic cancer	1.01e-05	0.000113	CcSEcCtD
Danazol—Hyperhidrosis—Doxorubicin—hematologic cancer	1.01e-05	0.000113	CcSEcCtD
Danazol—Dyspepsia—Epirubicin—hematologic cancer	9.93e-06	0.000111	CcSEcCtD
Danazol—Nausea—Dexamethasone—hematologic cancer	9.84e-06	0.00011	CcSEcCtD
Danazol—Nausea—Betamethasone—hematologic cancer	9.84e-06	0.00011	CcSEcCtD
Danazol—Fatigue—Epirubicin—hematologic cancer	9.72e-06	0.000109	CcSEcCtD
Danazol—Constipation—Epirubicin—hematologic cancer	9.64e-06	0.000108	CcSEcCtD
Danazol—Urticaria—Methotrexate—hematologic cancer	9.57e-06	0.000107	CcSEcCtD
Danazol—Dizziness—Prednisone—hematologic cancer	9.54e-06	0.000106	CcSEcCtD
Danazol—Body temperature increased—Methotrexate—hematologic cancer	9.53e-06	0.000106	CcSEcCtD
Danazol—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	9.51e-06	0.000106	CcSEcCtD
Danazol—Paraesthesia—Doxorubicin—hematologic cancer	9.37e-06	0.000105	CcSEcCtD
Danazol—Dyspepsia—Doxorubicin—hematologic cancer	9.19e-06	0.000103	CcSEcCtD
Danazol—Vomiting—Prednisone—hematologic cancer	9.17e-06	0.000102	CcSEcCtD
Danazol—Rash—Prednisone—hematologic cancer	9.09e-06	0.000102	CcSEcCtD
Danazol—Dermatitis—Prednisone—hematologic cancer	9.08e-06	0.000101	CcSEcCtD
Danazol—Headache—Prednisone—hematologic cancer	9.03e-06	0.000101	CcSEcCtD
Danazol—Fatigue—Doxorubicin—hematologic cancer	9e-06	0.0001	CcSEcCtD
Danazol—Urticaria—Epirubicin—hematologic cancer	8.96e-06	0.0001	CcSEcCtD
Danazol—Constipation—Doxorubicin—hematologic cancer	8.92e-06	9.96e-05	CcSEcCtD
Danazol—Body temperature increased—Epirubicin—hematologic cancer	8.92e-06	9.95e-05	CcSEcCtD
Danazol—Asthenia—Methotrexate—hematologic cancer	8.65e-06	9.65e-05	CcSEcCtD
Danazol—Nausea—Prednisone—hematologic cancer	8.57e-06	9.56e-05	CcSEcCtD
Danazol—Pruritus—Methotrexate—hematologic cancer	8.53e-06	9.52e-05	CcSEcCtD
Danazol—Urticaria—Doxorubicin—hematologic cancer	8.29e-06	9.26e-05	CcSEcCtD
Danazol—Body temperature increased—Doxorubicin—hematologic cancer	8.25e-06	9.21e-05	CcSEcCtD
Danazol—Asthenia—Epirubicin—hematologic cancer	8.09e-06	9.03e-05	CcSEcCtD
Danazol—Pruritus—Epirubicin—hematologic cancer	7.98e-06	8.91e-05	CcSEcCtD
Danazol—Dizziness—Methotrexate—hematologic cancer	7.97e-06	8.9e-05	CcSEcCtD
Danazol—Vomiting—Methotrexate—hematologic cancer	7.66e-06	8.56e-05	CcSEcCtD
Danazol—Rash—Methotrexate—hematologic cancer	7.6e-06	8.48e-05	CcSEcCtD
Danazol—Dermatitis—Methotrexate—hematologic cancer	7.59e-06	8.48e-05	CcSEcCtD
Danazol—Headache—Methotrexate—hematologic cancer	7.55e-06	8.43e-05	CcSEcCtD
Danazol—Asthenia—Doxorubicin—hematologic cancer	7.49e-06	8.36e-05	CcSEcCtD
Danazol—Dizziness—Epirubicin—hematologic cancer	7.46e-06	8.33e-05	CcSEcCtD
Danazol—Pruritus—Doxorubicin—hematologic cancer	7.38e-06	8.24e-05	CcSEcCtD
Danazol—Vomiting—Epirubicin—hematologic cancer	7.17e-06	8.01e-05	CcSEcCtD
Danazol—Nausea—Methotrexate—hematologic cancer	7.16e-06	7.99e-05	CcSEcCtD
Danazol—Rash—Epirubicin—hematologic cancer	7.11e-06	7.94e-05	CcSEcCtD
Danazol—Dermatitis—Epirubicin—hematologic cancer	7.1e-06	7.93e-05	CcSEcCtD
Danazol—Headache—Epirubicin—hematologic cancer	7.07e-06	7.89e-05	CcSEcCtD
Danazol—Dizziness—Doxorubicin—hematologic cancer	6.9e-06	7.7e-05	CcSEcCtD
Danazol—Nausea—Epirubicin—hematologic cancer	6.7e-06	7.48e-05	CcSEcCtD
Danazol—Vomiting—Doxorubicin—hematologic cancer	6.64e-06	7.41e-05	CcSEcCtD
Danazol—Rash—Doxorubicin—hematologic cancer	6.58e-06	7.35e-05	CcSEcCtD
Danazol—Dermatitis—Doxorubicin—hematologic cancer	6.57e-06	7.34e-05	CcSEcCtD
Danazol—Headache—Doxorubicin—hematologic cancer	6.54e-06	7.3e-05	CcSEcCtD
Danazol—Nausea—Doxorubicin—hematologic cancer	6.2e-06	6.92e-05	CcSEcCtD
Danazol—ESR1—Signaling Pathways—H3F3A—hematologic cancer	2.7e-06	4.72e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CDKN1A—hematologic cancer	2.7e-06	4.72e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GSTP1—hematologic cancer	2.69e-06	4.71e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—PTEN—hematologic cancer	2.69e-06	4.71e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CDKN1B—hematologic cancer	2.67e-06	4.68e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—HDC—hematologic cancer	2.67e-06	4.67e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—TSC2—hematologic cancer	2.65e-06	4.65e-05	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—AKT1—hematologic cancer	2.64e-06	4.63e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—NR3C1—hematologic cancer	2.64e-06	4.62e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—MAPK8—hematologic cancer	2.63e-06	4.61e-05	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—AKT1—hematologic cancer	2.62e-06	4.6e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PRKCZ—hematologic cancer	2.62e-06	4.59e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CASP3—hematologic cancer	2.62e-06	4.59e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—IL2—hematologic cancer	2.61e-06	4.58e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.6e-06	4.56e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—IL6—hematologic cancer	2.6e-06	4.56e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—EP300—hematologic cancer	2.56e-06	4.49e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—FGFR3—hematologic cancer	2.55e-06	4.47e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CCND1—hematologic cancer	2.55e-06	4.46e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—ABCB1—hematologic cancer	2.55e-06	4.46e-05	CbGpPWpGaD
Danazol—AR—Gene Expression—CREBBP—hematologic cancer	2.55e-06	4.46e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—JUN—hematologic cancer	2.54e-06	4.45e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PARP1—hematologic cancer	2.53e-06	4.44e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MAPK14—hematologic cancer	2.53e-06	4.42e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—SRC—hematologic cancer	2.49e-06	4.37e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—FBXW7—hematologic cancer	2.49e-06	4.36e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—ESR1—hematologic cancer	2.48e-06	4.34e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GSTM1—hematologic cancer	2.47e-06	4.33e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—NCOR1—hematologic cancer	2.47e-06	4.33e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CDKN1A—hematologic cancer	2.47e-06	4.32e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—PTEN—hematologic cancer	2.46e-06	4.31e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—FN1—hematologic cancer	2.45e-06	4.29e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—HDAC2—hematologic cancer	2.44e-06	4.28e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CXCR4—hematologic cancer	2.44e-06	4.28e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CDA—hematologic cancer	2.44e-06	4.27e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—VEGFA—hematologic cancer	2.43e-06	4.25e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—BAD—hematologic cancer	2.42e-06	4.24e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—NFKBIA—hematologic cancer	2.42e-06	4.24e-05	CbGpPWpGaD
Danazol—ESR1—Generic Transcription Pathway—MYC—hematologic cancer	2.42e-06	4.23e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—MAPK8—hematologic cancer	2.41e-06	4.21e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—STAT3—hematologic cancer	2.41e-06	4.21e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—AKT1—hematologic cancer	2.4e-06	4.2e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—NRAS—hematologic cancer	2.4e-06	4.2e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—NOTCH1—hematologic cancer	2.4e-06	4.2e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CBL—hematologic cancer	2.38e-06	4.17e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IL3—hematologic cancer	2.36e-06	4.13e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PC—hematologic cancer	2.35e-06	4.11e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CD80—hematologic cancer	2.35e-06	4.11e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—EP300—hematologic cancer	2.35e-06	4.11e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PIK3CG—hematologic cancer	2.34e-06	4.1e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—KIT—hematologic cancer	2.34e-06	4.1e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PTPN1—hematologic cancer	2.32e-06	4.06e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PTPN11—hematologic cancer	2.3e-06	4.03e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—MAPK3—hematologic cancer	2.3e-06	4.02e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—SRC—hematologic cancer	2.28e-06	4e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—MAPK14—hematologic cancer	2.28e-06	3.99e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—RASGRP1—hematologic cancer	2.28e-06	3.99e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—HSP90AA1—hematologic cancer	2.27e-06	3.98e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—SYK—hematologic cancer	2.27e-06	3.98e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GBA—hematologic cancer	2.27e-06	3.97e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—SLC35B2—hematologic cancer	2.27e-06	3.97e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—MYC—hematologic cancer	2.24e-06	3.91e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CREB1—hematologic cancer	2.23e-06	3.91e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—TGFB1—hematologic cancer	2.23e-06	3.9e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—VEGFA—hematologic cancer	2.22e-06	3.89e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—BRAF—hematologic cancer	2.2e-06	3.86e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—STAT3—hematologic cancer	2.2e-06	3.85e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—NRAS—hematologic cancer	2.19e-06	3.84e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—STAT1—hematologic cancer	2.19e-06	3.84e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—MTHFR—hematologic cancer	2.19e-06	3.83e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CCL2—hematologic cancer	2.18e-06	3.82e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IL6R—hematologic cancer	2.18e-06	3.81e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CREBBP—hematologic cancer	2.17e-06	3.8e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—NOTCH1—hematologic cancer	2.16e-06	3.79e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—MAPK3—hematologic cancer	2.1e-06	3.68e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—MTAP—hematologic cancer	2.07e-06	3.63e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MAP2K1—hematologic cancer	2.07e-06	3.63e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—KRAS—hematologic cancer	2.07e-06	3.62e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PIK3CD—hematologic cancer	2.06e-06	3.61e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—GRB2—hematologic cancer	2.05e-06	3.59e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PDGFA—hematologic cancer	2.04e-06	3.58e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—MYC—hematologic cancer	2.04e-06	3.58e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—TGFB1—hematologic cancer	2.04e-06	3.57e-05	CbGpPWpGaD
Danazol—PGR—Gene Expression—MAPK3—hematologic cancer	2.04e-06	3.57e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—KITLG—hematologic cancer	2.02e-06	3.53e-05	CbGpPWpGaD
Danazol—PGR—Gene Expression—MYC—hematologic cancer	1.98e-06	3.47e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—FGF2—hematologic cancer	1.97e-06	3.45e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—STAT5A—hematologic cancer	1.97e-06	3.45e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—CREBBP—hematologic cancer	1.96e-06	3.43e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CDKN2B—hematologic cancer	1.95e-06	3.42e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PIK3R1—hematologic cancer	1.94e-06	3.41e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.93e-06	3.37e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—PIK3CA—hematologic cancer	1.9e-06	3.32e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—JAK2—hematologic cancer	1.89e-06	3.31e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—KRAS—hematologic cancer	1.89e-06	3.31e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CD86—hematologic cancer	1.89e-06	3.31e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—HES1—hematologic cancer	1.86e-06	3.26e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NCOR1—hematologic cancer	1.85e-06	3.24e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—FHL2—hematologic cancer	1.85e-06	3.24e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MDM2—hematologic cancer	1.85e-06	3.23e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PIK3CG—hematologic cancer	1.84e-06	3.22e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—TP53—hematologic cancer	1.84e-06	3.21e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CSF2—hematologic cancer	1.83e-06	3.21e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—FGF1—hematologic cancer	1.83e-06	3.21e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—AGRN—hematologic cancer	1.81e-06	3.18e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—FOXO1—hematologic cancer	1.8e-06	3.16e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PDGFRB—hematologic cancer	1.8e-06	3.15e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MTOR—hematologic cancer	1.8e-06	3.14e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PIK3CB—hematologic cancer	1.8e-06	3.14e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PDGFRA—hematologic cancer	1.77e-06	3.11e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PRKCG—hematologic cancer	1.77e-06	3.1e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—JAK1—hematologic cancer	1.77e-06	3.1e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—HRAS—hematologic cancer	1.76e-06	3.07e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—PIK3CA—hematologic cancer	1.74e-06	3.04e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—IDH2—hematologic cancer	1.72e-06	3.01e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—HMMR—hematologic cancer	1.72e-06	3.01e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CREBBP—hematologic cancer	1.7e-06	2.98e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CDKN1B—hematologic cancer	1.68e-06	2.95e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—IL6—hematologic cancer	1.68e-06	2.94e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—TP53—hematologic cancer	1.68e-06	2.94e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CASP3—hematologic cancer	1.65e-06	2.89e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IL2RA—hematologic cancer	1.65e-06	2.89e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IL2—hematologic cancer	1.65e-06	2.89e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TERT—hematologic cancer	1.63e-06	2.86e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ARNTL—hematologic cancer	1.62e-06	2.83e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PIK3CD—hematologic cancer	1.61e-06	2.83e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CCND1—hematologic cancer	1.61e-06	2.81e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—HRAS—hematologic cancer	1.61e-06	2.81e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—JUN—hematologic cancer	1.6e-06	2.81e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—ALB—hematologic cancer	1.59e-06	2.79e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PDGFB—hematologic cancer	1.59e-06	2.79e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CA9—hematologic cancer	1.57e-06	2.75e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ACP5—hematologic cancer	1.57e-06	2.75e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TSC2—hematologic cancer	1.56e-06	2.73e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CDKN1A—hematologic cancer	1.55e-06	2.72e-05	CbGpPWpGaD
Danazol—AR—Gene Expression—MAPK3—hematologic cancer	1.55e-06	2.72e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—NCOR2—hematologic cancer	1.55e-06	2.72e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PTEN—hematologic cancer	1.55e-06	2.72e-05	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—AKT1—hematologic cancer	1.55e-06	2.71e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—IL6—hematologic cancer	1.54e-06	2.69e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PIK3R1—hematologic cancer	1.52e-06	2.67e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MAPK8—hematologic cancer	1.52e-06	2.66e-05	CbGpPWpGaD
Danazol—AR—Gene Expression—MYC—hematologic cancer	1.51e-06	2.65e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—FGFR3—hematologic cancer	1.5e-06	2.62e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MAPK14—hematologic cancer	1.48e-06	2.6e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—EP300—hematologic cancer	1.48e-06	2.59e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—IDH1—hematologic cancer	1.48e-06	2.59e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—TXN—hematologic cancer	1.46e-06	2.56e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GSTO1—hematologic cancer	1.46e-06	2.56e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ABCC3—hematologic cancer	1.46e-06	2.56e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—SRC—hematologic cancer	1.44e-06	2.52e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—FN1—hematologic cancer	1.44e-06	2.52e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—SPHK1—hematologic cancer	1.43e-06	2.51e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—BAD—hematologic cancer	1.42e-06	2.49e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NFKBIA—hematologic cancer	1.42e-06	2.49e-05	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—AKT1—hematologic cancer	1.42e-06	2.48e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PIK3CB—hematologic cancer	1.41e-06	2.46e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NOTCH1—hematologic cancer	1.41e-06	2.46e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—VEGFA—hematologic cancer	1.4e-06	2.45e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—STAT3—hematologic cancer	1.39e-06	2.43e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—NRAS—hematologic cancer	1.38e-06	2.42e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CD80—hematologic cancer	1.38e-06	2.41e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PIK3CG—hematologic cancer	1.37e-06	2.41e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—KIT—hematologic cancer	1.37e-06	2.41e-05	CbGpPWpGaD
Danazol—PGR—Gene Expression—AKT1—hematologic cancer	1.37e-06	2.41e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—UGT1A1—hematologic cancer	1.37e-06	2.41e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PTPN11—hematologic cancer	1.35e-06	2.37e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—SLC22A1—hematologic cancer	1.34e-06	2.34e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CRABP1—hematologic cancer	1.34e-06	2.34e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MAPK3—hematologic cancer	1.33e-06	2.32e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CREB1—hematologic cancer	1.31e-06	2.29e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ALOX5—hematologic cancer	1.3e-06	2.28e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—BRAF—hematologic cancer	1.29e-06	2.26e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MYC—hematologic cancer	1.29e-06	2.26e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—TGFB1—hematologic cancer	1.29e-06	2.25e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CCL2—hematologic cancer	1.28e-06	2.24e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IL6R—hematologic cancer	1.28e-06	2.24e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CREBBP—hematologic cancer	1.27e-06	2.23e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—NUP98—hematologic cancer	1.26e-06	2.21e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ADCY7—hematologic cancer	1.22e-06	2.15e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—NCOA3—hematologic cancer	1.22e-06	2.15e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MAP2K1—hematologic cancer	1.22e-06	2.13e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—NUP214—hematologic cancer	1.22e-06	2.13e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PTEN—hematologic cancer	1.22e-06	2.13e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PIK3CD—hematologic cancer	1.21e-06	2.12e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—MAPK3—hematologic cancer	1.2e-06	2.1e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ABCG2—hematologic cancer	1.19e-06	2.09e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—MTR—hematologic cancer	1.19e-06	2.09e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—KRAS—hematologic cancer	1.19e-06	2.09e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ENO2—hematologic cancer	1.17e-06	2.05e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—MYC—hematologic cancer	1.16e-06	2.04e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—EP300—hematologic cancer	1.16e-06	2.03e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—FGF2—hematologic cancer	1.16e-06	2.03e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PIK3R1—hematologic cancer	1.14e-06	2e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GSTT1—hematologic cancer	1.13e-06	1.98e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—JAK2—hematologic cancer	1.11e-06	1.94e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—SDC1—hematologic cancer	1.11e-06	1.94e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PIK3CA—hematologic cancer	1.09e-06	1.92e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MDM2—hematologic cancer	1.08e-06	1.9e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—TP53—hematologic cancer	1.06e-06	1.85e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MTOR—hematologic cancer	1.05e-06	1.85e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PIK3CB—hematologic cancer	1.05e-06	1.85e-05	CbGpPWpGaD
Danazol—AR—Gene Expression—AKT1—hematologic cancer	1.05e-06	1.83e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—HRAS—hematologic cancer	1.01e-06	1.77e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CDKN1B—hematologic cancer	9.89e-07	1.73e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CASP3—hematologic cancer	9.69e-07	1.7e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IL6—hematologic cancer	9.69e-07	1.7e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IL2—hematologic cancer	9.68e-07	1.69e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CCND1—hematologic cancer	9.43e-07	1.65e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—NQO1—hematologic cancer	9.42e-07	1.65e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CD44—hematologic cancer	9.42e-07	1.65e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—JUN—hematologic cancer	9.41e-07	1.65e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CDKN1A—hematologic cancer	9.12e-07	1.6e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PTEN—hematologic cancer	9.1e-07	1.59e-05	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—AKT1—hematologic cancer	8.94e-07	1.57e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CYCS—hematologic cancer	8.91e-07	1.56e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MAPK8—hematologic cancer	8.91e-07	1.56e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	8.86e-07	1.55e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—EP300—hematologic cancer	8.68e-07	1.52e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PIK3CA—hematologic cancer	8.58e-07	1.5e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—SRC—hematologic cancer	8.44e-07	1.48e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—VEGFA—hematologic cancer	8.22e-07	1.44e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—STAT3—hematologic cancer	8.14e-07	1.43e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NRAS—hematologic cancer	8.12e-07	1.42e-05	CbGpPWpGaD
Danazol—ESR1—Gene Expression—AKT1—hematologic cancer	8.07e-07	1.41e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GSTP1—hematologic cancer	7.86e-07	1.38e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MAPK3—hematologic cancer	7.78e-07	1.36e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MYC—hematologic cancer	7.57e-07	1.33e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TGFB1—hematologic cancer	7.55e-07	1.32e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ABCB1—hematologic cancer	7.44e-07	1.3e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—NCOR1—hematologic cancer	7.22e-07	1.26e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GSTM1—hematologic cancer	7.22e-07	1.26e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—AKT1—hematologic cancer	7.01e-07	1.23e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—KRAS—hematologic cancer	6.99e-07	1.22e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PIK3CA—hematologic cancer	6.42e-07	1.12e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—MTHFR—hematologic cancer	6.38e-07	1.12e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TP53—hematologic cancer	6.21e-07	1.09e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—HRAS—hematologic cancer	5.94e-07	1.04e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IL6—hematologic cancer	5.69e-07	9.96e-06	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PIK3CG—hematologic cancer	5.36e-07	9.39e-06	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—AKT1—hematologic cancer	5.25e-07	9.19e-06	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CREBBP—hematologic cancer	4.97e-07	8.7e-06	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PIK3CD—hematologic cancer	4.71e-07	8.25e-06	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ALB—hematologic cancer	4.65e-07	8.15e-06	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PIK3R1—hematologic cancer	4.45e-07	7.79e-06	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PIK3CB—hematologic cancer	4.11e-07	7.19e-06	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PTEN—hematologic cancer	3.55e-07	6.22e-06	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—EP300—hematologic cancer	3.38e-07	5.93e-06	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PIK3CA—hematologic cancer	2.5e-07	4.39e-06	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—AKT1—hematologic cancer	2.05e-07	3.58e-06	CbGpPWpGaD
